G. Om Reddy

1.2k total citations
58 papers, 1.0k citations indexed

About

G. Om Reddy is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, G. Om Reddy has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Organic Chemistry, 18 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in G. Om Reddy's work include Analytical Methods in Pharmaceuticals (12 papers), Analytical Chemistry and Chromatography (11 papers) and Inflammatory mediators and NSAID effects (8 papers). G. Om Reddy is often cited by papers focused on Analytical Methods in Pharmaceuticals (12 papers), Analytical Chemistry and Chromatography (11 papers) and Inflammatory mediators and NSAID effects (8 papers). G. Om Reddy collaborates with scholars based in India and United States. G. Om Reddy's co-authors include M.K. Srinivasu, J. Moses Babu, Kamlesh P. Vyas, K. Vyas, Monima Sarma, Arya Chatterjee, G. Madhusudhan, P. K. Dubey, Srinivas Nanduri and Sriram Rajagopal and has published in prestigious journals such as Journal of Hazardous Materials, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

G. Om Reddy

57 papers receiving 968 citations

Peers

G. Om Reddy

PHARM

SPECT

J. Moses Babu India

Tanja Gödecke United States

A. Lakshmana Rao India

Olimpo García‐Beltrán Colombia

Junko Koyama Japan

Tomomi Goto Japan

Matthias Niemitz Finland

Mike S. Lee United States

Atul A. Shirkhedkar India

Gabriele Caccialanza Italy

J. Moses Babu India

G. Om Reddy

256 ×0.8

PHARM

335 ×1.2

187 ×0.7

182 ×0.9

SPECT

257 ×1.5

Citations per year, relative to G. Om Reddy G. Om Reddy (= 1×) peers J. Moses Babu

Countries citing papers authored by G. Om Reddy

Since Specialization

Citations

This map shows the geographic impact of G. Om Reddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Om Reddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Om Reddy more than expected).

Fields of papers citing papers by G. Om Reddy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Om Reddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Om Reddy. The network helps show where G. Om Reddy may publish in the future.

Co-authorship network of co-authors of G. Om Reddy

This figure shows the co-authorship network connecting the top 25 collaborators of G. Om Reddy. A scholar is included among the top collaborators of G. Om Reddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Om Reddy. G. Om Reddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madhusudhan, G., et al.. (2005). A novel and short convergent approach for N -aryl-5-aminomethyl-2-oxazolidinone derivatives Linezolid and DUP-721. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 44(6). 1236–1238. 4 indexed citations

Madhusudhan, G., et al.. (2005). Synthesis of syn-N-aryl sulfonyl-4-substituted phenyl-2-oxo-1,3-oxazolidine-5- carboxylates and their conversion to ant-form using DBU †. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 44(2). 366–371. 1 indexed citations

Rao, B. Mallikarjuna, et al.. (2005). A stability indicating LC method for Rivastigmine hydrogen tartrate. Journal of Pharmaceutical and Biomedical Analysis. 37(1). 57–63. 36 indexed citations

Madhusudhan, G., et al.. (2004). Unusual migrations and cyclization in the preparation of β-azido alcohols from β-hydroxy esters. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 43(12). 2719–2723. 1 indexed citations

Madhusudhan, G., et al.. (2004). Studies on synthesis and anti-bacterial activity of novel 4-substituted phenyl-2-oxo-1,3-oxazolidine-5-carboxylates. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 43(5). 957–963. 3 indexed citations

Rao, B. Mallikarjuna, et al.. (2004). A validated chiral LC method for the enantioselective analysis of Levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide on amylose-based stationary phase. Journal of Pharmaceutical and Biomedical Analysis. 35(5). 1017–1026. 28 indexed citations

Kumar, Pramod, et al.. (2004). Synthesis and biological evaluation of thiophene [3,2-b] pyrrole derivatives as potential anti-inflammatory agents. Bioorganic & Medicinal Chemistry. 12(5). 1221–1230. 62 indexed citations

Nanduri, Srinivas, et al.. (2004). Synthesis and structure–activity relationships of andrographolide analogues as novel cytotoxic agents. Bioorganic & Medicinal Chemistry Letters. 14(18). 4711–4717. 168 indexed citations

Babu, J. Moses, et al.. (2003). Structural studies on the impurities of troglitazone. Journal of Pharmaceutical and Biomedical Analysis. 31(2). 271–281. 2 indexed citations

10.

Reddy, G. Om, et al.. (2002). SYNTHESIS OF TETRAHYDRO AND HEXAHYDRO TETRACYCLIC 1,5-BENZOXAZEPINES. Heterocyclic Communications. 8(2). 141–144. 1 indexed citations

11.

Babu, J. Moses, et al.. (2002). Isolation and characterisation of process-related impurities in rofecoxib. Journal of Pharmaceutical and Biomedical Analysis. 29(1-2). 355–360. 12 indexed citations

12.

Reddy, G. Om, et al.. (2002). Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methods. Journal of Pharmaceutical and Biomedical Analysis. 29(4). 593–607. 61 indexed citations

13.

Srinivasu, M.K., et al.. (2002). Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC. Journal of Pharmaceutical and Biomedical Analysis. 28(3-4). 493–500. 23 indexed citations

14.

Reddy, G. Om, et al.. (2001). LC determination of rofecoxib in bulk and pharmaceutical formulations. Journal of Pharmaceutical and Biomedical Analysis. 26(4). 617–628. 21 indexed citations

15.

Srinivasu, M.K., et al.. (2001). LC separation of ortho and meta isomers of celecoxib in bulk and formulations using a chiral column. Journal of Pharmaceutical and Biomedical Analysis. 25(1). 21–30. 13 indexed citations

16.

Rao, Kalapala Venkateswara, Anup Kumar Sadhukhan, Vilwanathan Ravikumar, et al.. (2000). Butyrolactones from Aspergillus terreus.. Chemical and Pharmaceutical Bulletin. 48(4). 559–562. 105 indexed citations

17.

Reddy, G. Om, et al.. (2000). LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography. Journal of Pharmaceutical and Biomedical Analysis. 22(4). 627–639. 28 indexed citations

18.

Vyas, K., et al.. (2000). Sparfloxacin, an antibacterial drug. Acta Crystallographica Section C Crystal Structure Communications. 56(3). e115–e116. 28 indexed citations

19.

Srinivasu, M.K., et al.. (2000). A validated LC method for the quantitative determination of celecoxib in pharmaceutical dosage forms and purity evaluation in bulk drugs. Journal of Pharmaceutical and Biomedical Analysis. 22(6). 949–956. 30 indexed citations

20.

Reddy, G. Om, et al.. (2000). LC method for the quantitative determination of oxaprozin and its impurities in the bulk drug. Journal of Pharmaceutical and Biomedical Analysis. 22(4). 651–659. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact